Beccar Varela Advises Lake Resources on the Closing of Asset Sale in Jujuy to Austroid Corporation for USD 9 Million
Beccar Varela advised Lake Resources on the closing of the transaction for the sale of three lithium brine assets to Austroid Corporation for USD 9 million.
‘Chambers Asia-Pacific 2025’ Band 1 in 11 practice areas
Lee & Ko was ranked Band 1 by ‘Chambers Asia-Pacific Guide 2025’ in 11 practice areas.
First time a Swiss Court will rule on a company’s liability for failure to prevent alleged bribery of foreign public official
Niederer Kraft Frey represented Trafigura at trial in the first case brought before a Swiss Court involving corporate liability for alleged failure to prevent bribery of a foreign public official.
Beccar Varela advises FCA Compañía Financiera on the issuance of Class XX Notes
Beccar Varela advised FCA Compañía Financiera S.A. on the issuance of Class XX Notes in two series:
Homburger advised UBS Switzerland AG on CHF 3.6 bn credit facilities for Alpiq
Homburger acted as counsel to UBS Switzerland AG in its capacity as mandated lead arranger,
Alpiq Holding AG secures CHF 3.6 billion debt financing
Niederer Kraft Frey advised Alpiq Holding AG on a revolving credit facilities agreement with an international syndicate of banks as lenders and a revolving loan facility agreement with a syndicate of Swiss banks as lenders.
Morgan & Morgan is recognized as Pro Bono Leading Lights 2024.
For twelve consecutive years, Morgan & Morgan has received the “Leading Lights” recognition in Latin America for the firm´s Pro Bono program.
MBH advises Beltone on its JVA with CRIF to launch Egypt’s second credit rating agency
We are pleased to announce that Matouk Bassiouny & Hennawy (“MBH”) acted as the lead legal counsel to Beltone Capital (“Beltone”)
TRANSACTION SUMMARY
DSK Legal assisted and advised Eternis Fine Chemicals Limited (“Eternis”) and Eternis Fine Chemicals UK Limited in relation to acquisition of 100% shareholding of Sharon Personal Care (“Sharon PC”),
Homburger advised Noema Pharma AG on its Series B extension financing round
On December 11, 2024, Noema Pharma AG announced that it has successfully closed a Series B extension financing round with an investment from EQT Life Sciences,